Scarica l'app Stockscreener
54.58
2.90%
-1.63
Dopo l'orario di chiusura:
54.58
Precedente Chiudi:
$56.21
Aprire:
$57.06
Volume 24 ore:
1.39M
Relative Volume:
1.04
Capitalizzazione di mercato:
$7.86B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-11.87
EPS:
-4.6
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
-7.94%
1M Prestazione:
+0.89%
6M Prestazione:
+69.66%
1 anno Prestazione:
-25.25%
Intervallo 1D:
$53.24
$57.90
Intervallo di 1 settimana:
$53.24
$60.45
Portata 52W:
$27.66
$76.61
Vaxcyte Inc Stock (PCVX) Company Profile
Nome
Vaxcyte Inc
Settore
Industria
Telefono
650-837-0111
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
54.58 | 7.86B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Reiterato | Needham | Buy |
| 2025-09-12 | Iniziato | Goldman | Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Iniziato | Goldman | Buy |
| 2023-12-07 | Iniziato | Mizuho | Buy |
| 2023-04-18 | Iniziato | TD Cowen | Outperform |
| 2023-01-03 | Reiterato | Needham | Buy |
| 2022-12-15 | Iniziato | Guggenheim | Buy |
| 2022-11-17 | Iniziato | BTIG Research | Buy |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-06-24 | Ripresa | Jefferies | Buy |
| 2020-07-07 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Iniziato | Needham | Buy |
Mostra tutto
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Love a little risk? Wall Street sees massive upside in Vaxcyte stock - MSN
Vaxcyte Inc Stock (ISIN: US92242T1016) Slides on Major Investor Stake Cut - AD HOC NEWS
Vaxcyte Shares Decline as Capital Research Global Investors Reduces Stake - National Today
Aug PostEarnings: Can Vaxcyte Inc continue delivering strong returnsQuarterly Market Review & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Vaxcyte (NASDAQ:PCVX) CAO Elvia Cowan Sells 2,500 Shares - MarketBeat
Vaxcyte (PCVX) finance SVP exercises options and sells 2,500 shares - Stock Titan
Vaxcyte (PCVX) COO logs planned stock sales and RSU tax withholding - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity By Investing.com - Investing.com South Africa
Jefferies Maintains Buy on Vaxcyte (PCVX) March 10, 2026 - Meyka
PCVX (NASDAQ: PCVX) Form 144: insider notice to sell RSU shares - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity - Investing.com UK
Understanding the Setup: (PCVX) and Scalable Risk - Stock Traders Daily
Vaxcyte’s Heavy Equity Raise and Wider Losses Could Be A Game Changer For Vaxcyte (PCVX) - simplywall.st
Neo Ivy Capital Management Has $2.99 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Vaxcyte (NASDAQ: PCVX) CTO reports stock awards and tax-related share disposals - Stock Titan
COO at Vaxcyte (PCVX) gets RSUs, options and withholds shares for tax - Stock Titan
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate - TipRanks
Does Heavy 2025 Loss and Large Equity Raise for Vaxcyte’s VAX-31 Shift the Bull Case (PCVX)? - Yahoo Finance
Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock. - Yahoo Finance
Vaxcyte, Inc. (PCVX) - DirectorsTalk Interviews
Vaxcyte, Inc. $PCVX Shares Sold by TD Asset Management Inc - MarketBeat
Vaxcyte Advances VAX-31 Toward Phase 3 As Valuation Gap Persists - Yahoo Finance
A Look At Vaxcyte (PCVX) Valuation As Share Price Momentum Rebuilds - Yahoo Finance
Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New FinancingHas The Bull Case Changed? - simplywall.st
Citigroup Inc. Sells 116,206 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
PCVX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Assessing Vaxcyte (PCVX) Valuation After Recent Share Price Volatility - simplywall.st
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
Westfield Capital Management Co. LP Purchases 663,817 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Vanguard Group Inc. Has $443.78 Million Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte (PCVX): BTIG Raises Price Target, Maintains Buy Rating | - GuruFocus
JPMorgan Chase & Co. Has $56.37 Million Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans - TipRanks
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge - Investing.com Nigeria
Vaxcyte (NASDAQ:PCVX) Shares Gap Down Following Weak Earnings - MarketBeat
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion By Investing.com - Investing.com Canada
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion - Investing.com Nigeria
Vaxcyte, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vaxcyte Inc (PCVX) Q4 2025 Earnings Call Highlights: Unprecedented Phase 2 Results and ... By GuruFocus - Investing.com Canada
Vaxcyte Inc (PCVX) Q4 2025 Earnings Call Highlights: Unprecedented Phase 2 Results and Strategic Advancements - GuruFocus
Vaxcyte Q4 Earnings Call Highlights - MarketBeat
Vaxcyte (NASDAQ:PCVX) Issues Quarterly Earnings Results - MarketBeat
Vaxcyte Q4 2025 Earnings Call Transcript - MarketBeat
Vaxcyte Launches New $500 Million ATM Equity Program - TipRanks
PCVX: VAX-31 advanced in late-stage trials, with strong financials and manufacturing readiness for 2026 - TradingView
Vaxcyte enters into sales agreement, may sell shares of common stock of up to $500 million - marketscreener.com
Vaxcyte Enters Into Sales Agreement, May Sell Shares Of Common Stock Of Up To $500 Million - TradingView
Vaxcyte Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Vaxcyte Q4 Loss Widens - marketscreener.com
Vaxcyte (NASDAQ: PCVX) launches $500M common stock sales plan - Stock Titan
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):